Expression of p300 and p300/CBP associated factor (PCAF) in actinic keratosis and squamous cell carcinoma of the skin

被引:12
|
作者
Bosic, Martina M. [1 ]
Brasanac, Dimitrije C. [1 ]
Stojkovic-Filipovic, Jelena M. [2 ,3 ]
Zaletel, Ivan V. [4 ]
Gardner, Jerad M. [5 ]
Cirovic, Sanja L. [1 ]
机构
[1] Univ Belgrade, Inst Pathol, Fac Med, Dr Subotica 1-2, Belgrade 11000, Serbia
[2] Univ Belgrade, Clin Dermatovenereol, Clin Ctr Serbia, Belgrade, Serbia
[3] Univ Belgrade, Fac Med, Belgrade, Serbia
[4] Univ Belgrade, Fac Med, Inst Histol & Embryol Aleksandar Dj Kostic, Belgrade, Serbia
[5] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA
关键词
p300; PCAF; Skin cancer; Epithelial-mesenchymal transition; Tissue microarray; EPITHELIAL-MESENCHYMAL TRANSITION; HIGH-RISK; HUMAN-PAPILLOMAVIRUS; E-CADHERIN; CANCER; SURVIVAL; CBP; EPIDEMIOLOGY; MUTATIONS; IMPACT;
D O I
10.1016/j.yexmp.2016.03.006
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
p300 and p300/CBP-associated factor (PCAF) are histone modifiers and transcriptional co-factors involved in a number of cell processes. We investigated their expression patterns in 79 actinic keratoses (AK), 45 cases of Bowen's disease (BD), and 168 invasive squamous cell carcinomas of the skin (SCC). Using tissue microarray and immunohistochemistry, we evaluated p300 and PCAF expression in relation to the type of the lesion and SCC prognostic parameters (grade, diameter, thickness and level of invasion). High nuclear expression of p300 (>60% of positive cells) (p = 0.001) and absent cytoplasmic expression (p = 0.026) were more frequent in SCC compared to AK and BD, respectively. Cytoplasmic expression of p300 was associated with the SCC invasion of subcutaneous fat and deeper tissues (p = 0.049). Diffuse distribution of cells with p300 nuclear expression was more commonly seen in BD and SCC compared to AK (p < 0.001), in moderately- and poorly-differentiated SCC compared to well-differentiated SCC (p < 0.001), in tumors thicker than 6 mm (p < 0.001), and in deeply invading tumors (p = 0.001). More frequent loss of PCAF nuclear expression was observed in SCC than in AK and BD (p < 0.001). Diffuse distribution of cells with PCAF cytoplasmic expression was more common in BD and SCC compared to AK (p < 0.001), and in poorly-differentiated SCC compared to well- and moderately-differentiated SCC (p < 0.001). Our results suggest that increase in nuclear expression of p300, as well as the presence of cytoplasmic but loss of nuclear expression of PCAF, could play an important role in the development and progression of cutaneous SCC. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:378 / 385
页数:8
相关论文
共 50 条
  • [21] Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer
    Gao, Yina
    Geng, Jingshu
    Hong, Xuan
    Qi, Jiping
    Teng, Yang
    Yang, Yang
    Qu, Di
    Chen, Gongyan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (02): : 760 - 767
  • [22] CBP/p300 in cell growth, transformation, and development
    Goodman, RH
    Smolik, S
    GENES & DEVELOPMENT, 2000, 14 (13) : 1553 - 1577
  • [23] The important role of the histone acetyltransferases p300/CBP in cancer and the promising anticancer effects of p300/CBP inhibitors
    Wu, Xin
    Zhang, Xin
    Tang, Shaoshan
    Wang, Yao
    CELL BIOLOGY AND TOXICOLOGY, 2025, 41 (01)
  • [24] Functional interaction between coactivators CBP/p300, PCAF, and transcription factor FKLF2
    Song, CZ
    Keller, K
    Murata, K
    Asano, H
    Stamatoyannopoulos, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (09) : 7029 - 7036
  • [25] Epigenetic Factor CBP/p300 in Pulmonary Arterial Hypertension
    Bourgeois, Alice
    Habbout, Karima
    Robert, William
    Orcholski, Mark
    Breuils-Bonnet, Sandra
    Paulin, Roxane
    Provencher, Steeve
    Bonnet, Sebastien
    Boucherat, Olivier
    CIRCULATION, 2019, 140
  • [26] p300/CBP keeps chromatin silent
    Wrighton, Katharine H.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2022, 29 (11) : 1039 - 1039
  • [27] p300 and CBP: Partners for life and death
    Giordano, A
    Avantaggiati, ML
    JOURNAL OF CELLULAR PHYSIOLOGY, 1999, 181 (02) : 218 - 230
  • [28] p300/CBP keeps chromatin silent
    Katharine H. Wrighton
    Nature Structural & Molecular Biology, 2022, 29 : 1039 - 1039
  • [29] Protein Lysine Acetylation by p300/CBP
    Dancy, Beverley M.
    Cole, Philip A.
    CHEMICAL REVIEWS, 2015, 115 (06) : 2419 - 2452
  • [30] CBP and p300: HATs for different occasions
    Kalkhoven, E
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (06) : 1145 - 1155